Boost clinical trial retention with participant engagement and adherence patterns Clinical trial participants are among a study’s most valuable assets – which is why Sponsors & CROs are increasingly investing to keep them on board, on track, and on the … Read More
Author Archives: Bernard Vrijens
Considerations for Ensuring Optimal Digital Adherence Monitoring
It’s no secret, recruiting clinical trial participants is difficult, time-consuming, and considerably expensive, all while dropout rates are notoriously high across therapeutic areas. Whatever the motive for dropout, the impact is huge. Trials can become underpowered and may not have … Read More
Mitigating the Risk of Trial Failure with Digital Adherence Monitoring
Drug development is inherently risky, with some analysis showing that just 13.8% of products that enter industry-sponsored Phase I trials go on to obtain FDA approval.1 Of course, the exact figure varies across therapy areas and development stages, but it is … Read More
Addressing Medication Adherence in Decentralized Clinical Trials
Adherence monitoring can minimize variability and maximize engagement in DCTs Decentralized clinical trials (DCT) are growing in popularity, thanks to their ability to tear down many of the long-standing barriers to robust medical research. And while this new model has … Read More
Improving Clinical Trial ROI with Medication Adherence Management
Study power is the Holy Grail of clinical trials, setting drug developers on the quickest path to market – but non-adherence causes costly detours. When participants do not take their medication as specified in the study protocol, it can result … Read More
Happy Holidays!
As we prepare to wrap up the year, we wanted to take an opportunity to reflect on the past twelve months. While COVID-19 had an unprecedented impact on our day-to-day lives, we can take solace in the fact that the … Read More
Could 2022 be the Year of Fully Deployed Digital Transformation?
If 2020 brought the challenges of 21st-century healthcare to the fore, 2021 has been the year of building the case for a new approach. But as we look ahead to 2022, how can we take what we have learned since … Read More
Medication Adherence: The True Barometer of Patient Engagement
Building sustainable patient-centric trials to weather the storm of COVID-19 involves the utilisation of smart connected devices and packaging to reduce the burden on patients … Read More
AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence … Read More